The global GMP Cytokines market size was valued at US$ 143 million in 2024 and is forecast to a readjusted size of USD 246 million by 2031 with a CAGR of 8.2% during review period.
Cytokines are a large group of small signalling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well. GMP Cytokines are intended for use in GMP manufacturing of investigational or marketed clinical products, such as cell therapy, gene therapy, tissue-engineered products and other fields.
Drivers:
Increasing demand for cell and gene therapies: The rise of cell-based and gene therapies, such as CAR-T therapies and regenerative medicine, has significantly increased the demand for high-quality, GMP (Good Manufacturing Practice) cytokines. Cytokines play a crucial role in cell expansion and differentiation, making them essential in the manufacturing process of these therapies.
Growth in biopharmaceutical R&D: The pharmaceutical industry's focus on developing innovative biologics, cancer immunotherapies, and personalized medicine has led to a surge in demand for GMP-grade cytokines. These are critical for ensuring the consistency, safety, and effectiveness of drug development and clinical trials.
Advances in stem cell research: The expansion of stem cell research, which requires high-quality cytokines for the differentiation and proliferation of stem cells, has further driven the demand for GMP-grade cytokines in both academic and industrial research settings.
Regulatory requirements: The need for compliance with regulatory standards, especially in clinical trials and drug manufacturing, has heightened the demand for GMP-certified cytokines. These stringent standards ensure that cytokines used in clinical and therapeutic applications are of the highest purity and quality.
Rising interest in cancer immunotherapy: Cytokines are essential components in cancer immunotherapies, which harness the body鈥檚 immune system to fight cancer. As immunotherapy research grows, so does the demand for GMP cytokines, particularly in the production of therapies targeting immune modulation.
Challenges:
High production costs: Producing GMP-grade cytokines involves stringent quality controls and highly specialized manufacturing processes, which significantly increase production costs. This makes GMP cytokines expensive, limiting their accessibility, especially for smaller research institutions and companies.
Complexity of manufacturing: The production of GMP cytokines requires sophisticated technologies, including recombinant protein production, purification, and quality control processes, which can be complex and time-consuming. Any deviation in these processes can lead to batch failures, affecting supply chain stability.
Regulatory hurdles: Obtaining regulatory approvals for GMP cytokines used in clinical applications can be a lengthy and challenging process. Manufacturers must meet stringent quality and safety standards, which can delay the availability of new products and limit market growth.
Supply chain issues: The production of GMP cytokines is highly dependent on reliable and consistent raw material supplies. Any disruptions in the supply chain, such as shortages of critical raw materials, can impact production timelines and availability, posing a challenge to manufacturers.
Competition from alternative technologies: As new technologies emerge in the biopharmaceutical industry, such as synthetic biology and non-cytokine-based methods for cell growth and differentiation, the demand for traditional cytokines could be threatened, impacting market growth in the long term.
This report is a detailed and comprehensive analysis for global GMP Cytokines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global GMP Cytokines market size and forecasts, in consumption value ($ Million), sales quantity (mg), and average selling prices (USD/碌g), 2020-2031
Global GMP Cytokines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (mg), and average selling prices (USD/碌g), 2020-2031
Global GMP Cytokines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (mg), and average selling prices (USD/碌g), 2020-2031
Global GMP Cytokines market shares of main players, shipments in revenue ($ Million), sales quantity (mg), and ASP (USD/碌g), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for GMP Cytokines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global GMP Cytokines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio-Techne, PeproTech, CellGenix, Miltenyi Biotec, Cytiva, Lonza, ReproCELL, Sino Biological, Akron Biotech, Creative Bioarray, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
GMP Cytokines market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
TNF
Interleukin
Growth Factor
Others
麻豆原创 segment by Application
Cell/Gene Therapy
Tissue-Engineered Products
Others
Major players covered
Bio-Techne
PeproTech
CellGenix
Miltenyi Biotec
Cytiva
Lonza
ReproCELL
Sino Biological
Akron Biotech
Creative Bioarray
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe GMP Cytokines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of GMP Cytokines, with price, sales quantity, revenue, and global market share of GMP Cytokines from 2020 to 2025.
Chapter 3, the GMP Cytokines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the GMP Cytokines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and GMP Cytokines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of GMP Cytokines.
Chapter 14 and 15, to describe GMP Cytokines sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global GMP Cytokines Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 TNF
1.3.3 Interleukin
1.3.4 Growth Factor
1.3.5 Others
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global GMP Cytokines Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Cell/Gene Therapy
1.4.3 Tissue-Engineered Products
1.4.4 Others
1.5 Global GMP Cytokines 麻豆原创 Size & Forecast
1.5.1 Global GMP Cytokines Consumption Value (2020 & 2024 & 2031)
1.5.2 Global GMP Cytokines Sales Quantity (2020-2031)
1.5.3 Global GMP Cytokines Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Bio-Techne
2.1.1 Bio-Techne Details
2.1.2 Bio-Techne Major Business
2.1.3 Bio-Techne GMP Cytokines Product and Services
2.1.4 Bio-Techne GMP Cytokines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Bio-Techne Recent Developments/Updates
2.2 PeproTech
2.2.1 PeproTech Details
2.2.2 PeproTech Major Business
2.2.3 PeproTech GMP Cytokines Product and Services
2.2.4 PeproTech GMP Cytokines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 PeproTech Recent Developments/Updates
2.3 CellGenix
2.3.1 CellGenix Details
2.3.2 CellGenix Major Business
2.3.3 CellGenix GMP Cytokines Product and Services
2.3.4 CellGenix GMP Cytokines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 CellGenix Recent Developments/Updates
2.4 Miltenyi Biotec
2.4.1 Miltenyi Biotec Details
2.4.2 Miltenyi Biotec Major Business
2.4.3 Miltenyi Biotec GMP Cytokines Product and Services
2.4.4 Miltenyi Biotec GMP Cytokines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Miltenyi Biotec Recent Developments/Updates
2.5 Cytiva
2.5.1 Cytiva Details
2.5.2 Cytiva Major Business
2.5.3 Cytiva GMP Cytokines Product and Services
2.5.4 Cytiva GMP Cytokines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Cytiva Recent Developments/Updates
2.6 Lonza
2.6.1 Lonza Details
2.6.2 Lonza Major Business
2.6.3 Lonza GMP Cytokines Product and Services
2.6.4 Lonza GMP Cytokines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Lonza Recent Developments/Updates
2.7 ReproCELL
2.7.1 ReproCELL Details
2.7.2 ReproCELL Major Business
2.7.3 ReproCELL GMP Cytokines Product and Services
2.7.4 ReproCELL GMP Cytokines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 ReproCELL Recent Developments/Updates
2.8 Sino Biological
2.8.1 Sino Biological Details
2.8.2 Sino Biological Major Business
2.8.3 Sino Biological GMP Cytokines Product and Services
2.8.4 Sino Biological GMP Cytokines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Sino Biological Recent Developments/Updates
2.9 Akron Biotech
2.9.1 Akron Biotech Details
2.9.2 Akron Biotech Major Business
2.9.3 Akron Biotech GMP Cytokines Product and Services
2.9.4 Akron Biotech GMP Cytokines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Akron Biotech Recent Developments/Updates
2.10 Creative Bioarray
2.10.1 Creative Bioarray Details
2.10.2 Creative Bioarray Major Business
2.10.3 Creative Bioarray GMP Cytokines Product and Services
2.10.4 Creative Bioarray GMP Cytokines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Creative Bioarray Recent Developments/Updates
3 Competitive Environment: GMP Cytokines by Manufacturer
3.1 Global GMP Cytokines Sales Quantity by Manufacturer (2020-2025)
3.2 Global GMP Cytokines Revenue by Manufacturer (2020-2025)
3.3 Global GMP Cytokines Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of GMP Cytokines by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 GMP Cytokines Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 GMP Cytokines Manufacturer 麻豆原创 Share in 2024
3.5 GMP Cytokines 麻豆原创: Overall Company Footprint Analysis
3.5.1 GMP Cytokines 麻豆原创: Region Footprint
3.5.2 GMP Cytokines 麻豆原创: Company Product Type Footprint
3.5.3 GMP Cytokines 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global GMP Cytokines 麻豆原创 Size by Region
4.1.1 Global GMP Cytokines Sales Quantity by Region (2020-2031)
4.1.2 Global GMP Cytokines Consumption Value by Region (2020-2031)
4.1.3 Global GMP Cytokines Average Price by Region (2020-2031)
4.2 North America GMP Cytokines Consumption Value (2020-2031)
4.3 Europe GMP Cytokines Consumption Value (2020-2031)
4.4 Asia-Pacific GMP Cytokines Consumption Value (2020-2031)
4.5 South America GMP Cytokines Consumption Value (2020-2031)
4.6 Middle East & Africa GMP Cytokines Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global GMP Cytokines Sales Quantity by Type (2020-2031)
5.2 Global GMP Cytokines Consumption Value by Type (2020-2031)
5.3 Global GMP Cytokines Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global GMP Cytokines Sales Quantity by Application (2020-2031)
6.2 Global GMP Cytokines Consumption Value by Application (2020-2031)
6.3 Global GMP Cytokines Average Price by Application (2020-2031)
7 North America
7.1 North America GMP Cytokines Sales Quantity by Type (2020-2031)
7.2 North America GMP Cytokines Sales Quantity by Application (2020-2031)
7.3 North America GMP Cytokines 麻豆原创 Size by Country
7.3.1 North America GMP Cytokines Sales Quantity by Country (2020-2031)
7.3.2 North America GMP Cytokines Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe GMP Cytokines Sales Quantity by Type (2020-2031)
8.2 Europe GMP Cytokines Sales Quantity by Application (2020-2031)
8.3 Europe GMP Cytokines 麻豆原创 Size by Country
8.3.1 Europe GMP Cytokines Sales Quantity by Country (2020-2031)
8.3.2 Europe GMP Cytokines Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific GMP Cytokines Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific GMP Cytokines Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific GMP Cytokines 麻豆原创 Size by Region
9.3.1 Asia-Pacific GMP Cytokines Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific GMP Cytokines Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America GMP Cytokines Sales Quantity by Type (2020-2031)
10.2 South America GMP Cytokines Sales Quantity by Application (2020-2031)
10.3 South America GMP Cytokines 麻豆原创 Size by Country
10.3.1 South America GMP Cytokines Sales Quantity by Country (2020-2031)
10.3.2 South America GMP Cytokines Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa GMP Cytokines Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa GMP Cytokines Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa GMP Cytokines 麻豆原创 Size by Country
11.3.1 Middle East & Africa GMP Cytokines Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa GMP Cytokines Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 GMP Cytokines 麻豆原创 Drivers
12.2 GMP Cytokines 麻豆原创 Restraints
12.3 GMP Cytokines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of GMP Cytokines and Key Manufacturers
13.2 Manufacturing Costs Percentage of GMP Cytokines
13.3 GMP Cytokines Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 GMP Cytokines Typical Distributors
14.3 GMP Cytokines Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Bio-Techne
PeproTech
CellGenix
Miltenyi Biotec
Cytiva
Lonza
ReproCELL
Sino Biological
Akron Biotech
Creative Bioarray
听
听
*If Applicable.
